Vote Scores

Home / Companies / Sage Therapeutics, Inc. / 10 Jun 2024

Meeting · year to 30 June 2024305 filers reporting

Sage Therapeutics, Inc.: meeting of 10 Jun 2024

Votes reported on Form N-PX, item by item

305 Form N-PX filers reported votes at the Sage Therapeutics, Inc. meeting of 10 Jun 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 45.4% of reported votes for; 91 filers withheld from or voted against at least one nominee.

439 vote records from 118 filers. 29 of the 117 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

24.6% for0.0% against75.4% other24.8% against management118 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

446 vote records from 299 filers. 25 of the 290 filers that marked the item either way voted against management. 9 filers reported this item without a management mark.

88.6% for8.0% against3.3% other8.6% against management299 filers98.1% for1.8% against0.2% other1.8% against management56,439,223 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

219 vote records from 117 filers. 1 of the 116 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

98.3% for0.0% against1.7% other0.9% against management117 filers100.0% for0.0% against0.0% other0.0% against management22,284,700 reported shares
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

221 vote records from 118 filers. 58 of the 117 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

49.2% for49.2% against1.7% other49.6% against management118 filers78.1% for21.9% against21.9% against management22,284,910 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesSplit or no voteForFor
FidelityAbstain or withhold *ForFor
DimensionalAbstain or withhold *ForFor
State Street and SPDRAbstain or withhold *ForFor
American CenturySplit or no voteAgainst *For
InvescoSplit or no voteForFor
EquitableAbstain or withhold *ForFor
Charles SchwabSplit or no voteForFor
Nuveen and TIAAForForFor
ProShares and ProFundsSplit or no voteForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertSplit or no voteForFor
J.P. MorganForForFor
Goldman SachsNo reportForNo report
PGIM and PrudentialForAgainst *For
Jackson National fundsAbstain or withhold *ForFor
Northern Trust and FlexSharesAbstain or withhold *ForFor
SEIAbstain or withhold *ForFor
T. Rowe PriceForForFor
Lincoln FinancialAbstain or withhold *ForFor
VoyaAbstain or withhold *ForFor
Russell InvestmentsForForFor
NationwideSplit or no voteForFor
Victory CapitalSplit or no voteForFor
Brighthouse FundsSplit or no voteForFor
Guggenheim and RydexSplit or no voteForFor
Columbia ThreadneedleSplit or no voteForFor
BNY MellonNo reportForNo report
PrincipalForForFor
Pacific Life fundsSplit or no voteForFor
Global XAbstain or withhold *ForFor
Federated HermesAbstain or withhold *ForFor
AllianceBernsteinNo reportForNo report
DWSAbstain or withhold *ForFor
AllspringSplit or no voteForFor
Harbor FundsForForFor
Janus HendersonNo reportForNo report
Neuberger BermanNo reportForNo report
Natixis and Loomis SaylesNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Sage Therapeutics, Inc. meeting?

305 Form N-PX filers reported votes at the meeting of 10 Jun 2024. On say-on-pay, 25 of 290 voted against management (8.6%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Sage Therapeutics, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Sage Therapeutics, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Sage Therapeutics, Inc. with a meeting date within three days of 10 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.